📰 Katalyst Securities News
Katalyst Securities News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Katalyst Securities. Real-time updates on events, politics, business and more.
July 6, 2023
Investors Bolster Support in Public Safety Technology, Boosting Cash Reserves to Over $20M through Equity Transaction...
June 23, 2023
/PRNewswire/ -- SmartKem, Inc. ("SmartKem" or the "Company") (OTCQB: SMTK), a company seeking to reshape the world of electronics with its disruptive organic...
February 21, 2023
MyMD Pharmaceuticals, Inc.® , a clinical stage biopharmaceutical company developing groundbreaking therapies for the treatment of serious and debilitating autoimmune and inflammatory diseases,... | February 21, 2023
November 18, 2022
Topline data from NIH-supported Phase 2 clinical trial for advanced AD patients expected during the current quarterNEW YORK, Nov. 18, 2022 /PRNews...
December 28, 2021
NEW YORK, Dec. 28, 2021 Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provider of therapeutics for mens health, today announced the closing of its...
December 22, 2021
/PRNewswire/ -- Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provider of therapeutics for mens health, today announced that it has entered into...
December 22, 2021
/PRNewswire/ -- Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provider of therapeutics for mens health, today announced that it has entered into...
December 2, 2021
/PRNewswire/ -- Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provider of therapeutics for mens health, today announced the closing of its previously...
December 2, 2021
/PRNewswire/ -- Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provider of therapeutics for mens health, today announced the closing of its previously...
November 30, 2021
/PRNewswire/ -- Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provider of therapeutics for mens health, today announces that it has entered into...